The marijuana industry has benefitted from a massive influx of capital over the course of the past few years. With so much happening throughout the market in terms of innovation and investments, many cannabis companies have managed to slip under the radar despite being undervalued at the current point in time.
A new research report has shown that the sales of cannabis around the world may rise as much as 38% during the next year to as high as $16.9 billion. This is a staggering jump and leaves a large amount of room for more companies to get involved in the cannabis space. Wall Street has been betting on this increase and has since been seen working to get more involved in the marijuana industry.
CLS Holdings USA (CLSH) is a pharmaceutical company that works with various cannabinoids from the marijuana plant. The company has seen its stock shoot up by as much as 20% in the past several weeks which is a major indicator of their short term successes. CLS states that they are a “diversified cannabis company that acts as an integrated cannabis producer and retailer.” They do this through various subsidiaries that they own such as Oasis Cannabis which is based out of Nevada.
Currently, CLS or Cannabis Life Sciences is working on producing various extractions made from the cannabis plant through their proprietary technology that results in extremely high quality.
In addition to this quality, CLS is able to maintain a high level of consistency which is something many medicinal patients look for. With cannabis, often times one of the difficulties is that there is not a large amount of consistency among products. CLS however, is working to change this into the future.
Emerald Health Therapeutics (EMHTF) is one of the big players in the cannabis growing market. The company several months ago made headlines after forming a joint venture with Village Farms International, known now as Pure Sunfarms.
The pair is working to build out as much as 1.1 million square feet of growing space purely dedicated to the world of cannabis. When they are operating at full capacity, the pair should be able to produce as much as 100,000 kilograms of cannabis. This number is quite large considering some of the smaller players in the industry as well as the big guys.
According to one report, next to their newest facility is an additional 3.7 million square feet of land that could be utilized for even more expansion if they choose to do so in the near future. One of the issues with the company, however, is that their yields are still relatively low compared to the big players in the market. Some Wall Street estimates have put their target price at around 109% higher which helps to show how much value investors believe the company has in the coming years.
All in all, the undervaluing of some companies may result as a benefit for a few investors. The cannabis industry, however, is still very new which means there is hopefully an even brighter future to look forward to.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and CLS Holdings USA Inc. (CLSH), Midam has been paid $100,000 from CLS Holdings USA Inc. (CLSH) for a period from November 30, 2018 to December 30, 2018. We have been compensated an additional $100,000 ( CASH) from CLS Holdings USA extending the contract another 30 days ending January 31, 2019. We may buy or sell additional shares of (CLSH) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about CLS Holdings USA Inc. (CLSH). “Click here for full disclaimer”